News Affluent Medical

Equities

AFME

FR0013333077

Market Closed - Euronext Paris Other stock markets 10:35:14 2024-06-11 am EDT			5-day change	1st Jan Change
1.745 ^EUR	-0.57%		-3.86%	-5.42%

Apr. 25	Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	AFFLUENT MEDICAL : Invest Securities reiterates its opinion	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Affluent Medical : 2023 financial results and update on clinical activities under development.	Apr. 25	EQ
Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.	Apr. 04	EQ
Affluent Medical : announces coverage initiation of its stock by TP ICAP Midcap.	Mar. 28	PU
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.	Mar. 28	EQ
AFFLUENT MEDICAL : Invest Securities reiterates its opinion	Mar. 13	CF
Affluent Medical: 1st human implantation of 'Artus	Mar. 12	CF
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.	Mar. 12	EQ
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.	Feb. 29	EQ
Affluent Medical Obtains Bridge Financing to Fund Operations	Jan. 30	MT
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders.	Jan. 29	EQ
Affluent Medical : Half-year liquidity contract statement for Affluent Medical.	Jan. 29	EQ
Affluent Medical SA announced that it has received ?3.5 million in funding	Jan. 28	CI
Affluent Medical : Pre-submission dossier for the 510(k) of medical device KaliosTM filed with FDA for review.	Jan. 15	EQ
Affluent Medical : Start of the European pilot study with the Artus medical device for the treatment of urinary incontinence.	Dec. 06	EQ
Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.	Nov. 27	EQ
Affluent Medical : H1 2023 results. Major advances in clinical programs. Extension of cash horizon to February 2024.	23-09-28	EQ
Affluent Medical SA: H1 2023 RESULTS - Major advances in clinical programs - Extension of cash horizon to February 2024	23-09-28	EQ
Affluent Medical SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
Affluent Medical: positive results in cardiology	23-09-14	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Affluent Medical

Equities

AFME

FR0013333077

Summary

Filters